@hairycellleukemia

The Hairy Cell Leukemia Foundation serves as a central knowledge hub for this rare blood cancer, maintaining an extensive database of clinical research and treatment protocols. Their digital platform synthesizes findings from pivotal studies on combination therapies, particularly the breakthrough applications of cladribine with rituximab. The foundation's evidence repository includes longitudinal data on complete response rates and survival outcomes from major treatment centers. The organization provides structured support through specialized educational materials, including detailed treatment decision frameworks and symptom management guides developed by hematology experts. Their provider network connects patients with physicians experienced in hairy cell leukemia care across multiple institutions. Clinical partnerships enable direct routing to specialists at major cancer centers maintaining active HCL research programs. The foundation coordinates the international Hairy Cell Leukemia Patient Registry, collecting standardized data on disease progression, treatment responses, and long-term outcomes. Registry participants contribute to an evolving knowledge base that informs therapeutic protocols and clinical practice guidelines. This real-world evidence supplements controlled trials in advancing scientific understanding of this rare hematologic malignancy.